# Protalix BioTherapeutics, Inc.: Form 8-K, filed Apr 16, 2018

- Company: [Protalix BioTherapeutics, Inc.](/companies/plx.md) (CIK 1006281)
- Form: 8-K
- Filed: 2018-04-16
- Accepted by EDGAR: Apr 16, 2018, 16:06 ET
- Period: 2018-04-15
- Accession: 0001144204-18-020721
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1006281/000114420418020721/tv491150_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1006281/000114420418020721/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1006281/000114420418020721/tv491150_8k.htm

Filed Apr 16, 2018.
Source: SEC EDGAR, the filing index for accession 0001144204-18-020721. Last ingested by Listed: Nov 10, 2026, 16:48 ET. No prices; not investment advice.
